Syngene to acquire Stelis Biopharma’s biologics manufacturing facility in Bangalore

By on    Pharma Industry News  

Syngene to acquire Stelis Biopharma’s biologics manufacturing facility in Bangalore

Pharma manufacturing services company Syngene International has unveiled plans to acquire Unit 3 biologics manufacturing facility located in Bangalore, India from Stelis Biopharma Limited (SBL). The agreement will result in an additional 20,000 liters of installed biologics drug substance manufacturing capacity for Syngene, with the possibility of doubling this figure in the future. The facility […]

Syngene signs Librela-focused biologics manufacturing agreement with Zoetis

By on    Healthcare Industry News  

Syngene signs Librela-focused biologics manufacturing agreement with Zoetis

Syngene International Limited has signed a 10-year biologics manufacturing agreement with American animal health company Zoetis for manufacturing the drug substance for Librela (bedinvetmab), a first in class monoclonal antibody used for the treatment of osteoarthritis in dogs. The Indian research, development, and manufacturing services company has been collaborating with Zoetis since 2011. During this […]